Still, the analysts predicted that Ozempic, Wegovy, and Rybelsus (semaglutide) maker Novo Nordisk and Eli Lilly, which developed Zepbound and Mounjaro (tirzepatide), will maintain two-thirds of the market by 2031 due to their first-mover advantages. Other competitors are expected to take a combined $70 billion of the GLP-1 market, the study read
Below are eight transformation goals for all of us women in midlife not as resolutions, but as identity-level shifts that support hormone health, emotional wellbeing, sustained energy, and a deeper sense of self-trust
Br J Dermatol (2012) 166(6):118497
If you are pregnant, nursing, have a medical condition or are taking any medications, please consult your healthcare provider before using these products
PRODUCT INFORMATION OF LUTHIONE 1200MG INJECTION Packaging: 10 vials per box
References Srensen TIA, Martinez AR, Jrgensen TSH